We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Coalition Warns Administration’s Drug Pricing Index Would Limit Access
Coalition Warns Administration’s Drug Pricing Index Would Limit Access
A coalition of more than 200 healthcare advocacy and biopharma groups warned congressional leaders on Monday of unintended consequences of the Trump administration’s proposal to tie Medicare Part B drug prices to those of foreign countries.